Vanguard Group Inc Amneal Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
249Shares Held
144MCall Options Held
194KPut Options Held
49.3K-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$128 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$122 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$117 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$58.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.3MShares$55 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.57B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...